Purpura annularis telangiectodes of Majocchi

Authors

DOI:

https://doi.org/10.61997/bjm.v15i1.493

Keywords:

Pigmented purpuric dermatosis, Majocchi's disease

Abstract

N/A

 

Downloads

Download data is not yet available.

References

Díaz Morejón L de la C, Betancourt Trijillo MR, León Rayas Y, López Hurtado LO. Majocchi’s disease. Report of a pediatric case. Belize J Med. 2025; 14(3). doi: 10.61997/bjm.v14i3.486 DOI: https://doi.org/10.61997/bjm.v14i3.486

Al Salmi A, Al Shibli A, Al-Saadi M. Purpura annularis telangiectodes of Majocchi following a booster dose of the Pfizer-BioNTech COVID-19 vaccine: Coincidence or correlation? Cureus. 2025; 17(2):e78336. doi: 10.7759/cureus.78336 DOI: https://doi.org/10.7759/cureus.78336

Ambrogio F, Laface C, Sbarra G, Filotico R, Ranieri G, Barlusconi C, et al. A case of purpura annularis telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech vaccine: Is there an association? Vaccines (Basel). 2022;10(11):1972. 10.3390/vaccines10111972 DOI: https://doi.org/10.3390/vaccines10111972

Burghaus J, Enk A, Toberer F. [Purpura annularis telangiectodes: Case report and review of the literature]. Hautarzt. 2021;72(1):65-70. doi: 10.1007/s00105- 020-04667-3 DOI: https://doi.org/10.1007/s00105-020-04667-3

Chaisrimaneepan N, Manupeerapun H, Khoruamklang T. Pigmented purpuric dermatosis (Majocchi type) in a patient with vitiligo. Clin Case Rep. 2024; 12(3):e8609. doi: 10.1002/ccr3.8609 DOI: https://doi.org/10.1002/ccr3.8609

Downloads

Published

15-01-2026

How to Cite

Modesto dos Santos, V., Modesto Sugai, K., & Campos Nunes, R. (2026). Purpura annularis telangiectodes of Majocchi . Belize Journal of Medicine, 15(1). https://doi.org/10.61997/bjm.v15i1.493

Issue

Vol. 15 No. 1 (2026): January-April

Section

Correspondence

License

Copyright (c) 2026 Vitorino Modesto dos Santos, Kin Modesto Sugai, Rafael Campos Nunes

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

BJM protects Copyright at all times. However, it gives up part of the rights by displaying a Creative Commons License 4.0 (cc-by-nc), which allows the use of the work to share (copy and redistribute the material in any support or format) and adapt (transform and built from the material) as long as exclusive mention of the publication in the journal as the primary source is made. Under no circumstances, the work can be commercialized.